Digestive Enzymes Market by Enzyme Type (Alpha-Galactosidase, Carbohydrase, Lipase), Form (Chewables, Liquids, Powders), Origin, End-Use - Global Forecast 2024-2030

Digestive Enzymes Market by Enzyme Type (Alpha-Galactosidase, Carbohydrase, Lipase), Form (Chewables, Liquids, Powders), Origin, End-Use - Global Forecast 2024-2030

The Digestive Enzymes Market size was estimated at USD 906.54 million in 2023 and expected to reach USD 979.88 million in 2024, at a CAGR 8.40% to reach USD 1,595.40 million by 2030.

The digestive enzymes market encompasses a broad array of products designed to aid digestion by breaking down complex molecules such as proteins, fats, and carbohydrates into simpler forms that the body can easily absorb. These products find application across dietary supplements, pharmaceuticals, and animal feed sectors, addressing the needs of individuals with digestive disorders, those seeking wellness and dietary support and enhancing nutritional absorption in animals. Growth in the digestive enzymes market is influenced by several factors, including increasing incidences of gastrointestinal disorders, a rising elderly population vulnerable to digestive ailments, the growing awareness of the importance of digestive health, advancements in enzyme engineering and fermentation technology, and the expanding use of digestive enzymes in animal nutrition to enhance feed efficacy. However, limitations, including the high cost of enzyme production, strict regulatory frameworks guiding enzyme supplementation, potential side effects, and allergies associated with enzyme ingestion, can hinder market growth. Furthermore, the opportunities within the digestive enzymes market are vast, encompassing the expansion into emerging markets, personalized healthcare and nutrition planning, integration of plant-based and microbial enzymes, and enhancing enzyme stability and efficacy through microencapsulation and other innovative delivery technologies. These opportunities are poised to drive market expansion, cater to unmet needs, and inspire new applications and research avenues.

Regional Insights

In the Americas, the United States represents a major market for digestive enzymes, driven by a high prevalence of gastrointestinal disorders, a well-established healthcare sector, and consumer preference for dietary supplements. The trend towards natural and organic supplements further fuels the demand. Canada, following the United States, shows a growing interest in digestive health products, supported by health-conscious consumers and the availability of diverse supplements. The European market is characterized by stringent regulations and a well-informed consumer base demanding high-quality digestive aids. The EU's focus on safety and efficacy has led to rigorous approval processes for digestive enzymes. However, an aging population and a rising preference for preventive healthcare drive the market's growth. In MEA, the market is emerging, with the Middle East experiencing a surge in demand due to increasing lifestyle disorders and improving healthcare infrastructure. Africa, though still a nascent market, shows potential for growth with rising awareness of nutritional supplements. The APAC region is witnessing rapid growth in the digestive enzymes market, driven by China, Japan, and India. Consumer need in these countries is primarily influenced by an increasing elderly population, a rising middle class with disposable income, and a cultural inclination towards natural and alternative medicines.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Digestive Enzymes Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increasing gastrointestinal issues among the geriatric population
Rising prevalence toward plant-based digestive enzymes
Increasing lactose intolerant population

Market Restraints

Inadequate synthesis of certain digestive enzymes

Market Opportunities

Rising adoption of digestive enzymes in feed production
Significant shift toward personalized medicine

Market Challenges

Issues related to lack of targeted action and patient immune system reaction against the enzyme

Market Segmentation Analysis

Enzyme Type: Growing preference towards maltase enzyme for both health supplements and food processing applications
End-Use: Expanding application of digestive enzymes in animal nutrients for feed efficiency and growth performance

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Digestive Enzymes Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Digestive Enzymes Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Introduction of Humiome B2 by DSM-Firmenich, a Biotic Vitamin B2 for Enhanced Colon Health

DSM-Firmenich is set to release Humiome B2, the inaugural product positioned as the world's first biotic vitamin, at Vitafoods Europe. This innovative form of vitamin B2 leverages the company's proprietary microbiome-targeted technology (MTT) to ensure optimal delivery to the colon, promising not just nutrient absorption but also prebiotic-like benefits. By aligning with the holistic health aspirations of today's consumers, this product also offers formulators extended vitamin stability against environmental factors. The company is expanding in Europe, the Middle East, Africa, and North America, with plans for further expansion.

Alcresta Therapeutics Advances Enteral Nutrition with FDA-Cleared RELiZORB Digestive Enzyme Cartridge

Alcresta Therapeutics has achieved a significant milestone with the FDA's 510(k) clearance of its advanced digestive enzyme cartridge, RELiZORB, aimed at enhancing enteral nutrition for patients with rare diseases. The updated RELiZORB supports a wider range of enteral nutrition formulas and can be used with both continuous and bolus feeding methods, improving its usability for patients suffering from short bowel syndrome (SBS). Results from recent pre-clinical studies at Boston Children’s Hospital underscore the efficacy and safety of RELiZORB for these feeding methods. With commercial availability expected by the second quarter of 2024, the enhanced RELiZORB promises to improve nutritional outcomes for tube-fed patients significantly.

Kerry Group Enhances Biotechnology Portfolio with Strategic Acquisition of Lactase Enzyme Business

Kerry Group plc, announced a definitive agreement to acquire segments of the lactase enzyme division from Chr. Hansen Holding A/S and Novozymes A/S, known collectively as the Lactase Enzymes Business. This acquisition is pending European Commission approval and is integral to the merger process between Novozymes and Chr. Hansen is valued at Euro150 million (USD 161.422 million). The inclusion of the NOLA Products bolsters Kerry's existing capabilities by adding advanced enzyme technology that facilitates the production of lactose-free and sugar-reduced dairy products. This move is in response to growing consumer demand driven by both increased awareness of lactose intolerance and lifestyle choices favoring such products.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Digestive Enzymes Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Digestive Enzymes Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amway Corporation, Antozyme Biotech Pvt Ltd, AST Enzyme, Aumenzymes, BASF SE, Biotics Research Corporation, Country Life LLC, Digestive Care, Inc., Eisai Co., Ltd., Enzymedica, Enzymes Inc., FitLife Brands, Inc., GENETIC NUTRITION, iHerb, LLC, Integrative Therapeutics, LLC, Koninklijke DSM N.V., Nestle SA, OneroRx, Inc., Specialty Enzymes & Probiotics, and Zeus Biotech Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Digestive Enzymes Market to forecast the revenues and analyze trends in each of the following sub-markets:

Enzyme Type
Alpha-Galactosidase
Carbohydrase
Lipase
Maltase
Protease
Form
Chewables
Liquids
Powders
Tablets & Capsules
Origin
Animal
Microbial
Plant
End-Use
Animal Nutrition
Aquaculture
Cattle Feed
Pet Food
Poultry Feed
Swine
Human Nutrition
Dietary Supplements
Infant Nutrition
Sports Nutrition
Pharmaceuticals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year